Summertime and the livin’ is easy…and sometimes incredibly hot. As we race toward summer homes, vacation spots or just hang around the City, we have to be mindful that hot temperatures can be very dangerous wherever we are. Heat advisories should be taken seriously especially when high temperatures and humidity can produce heat indices between

According to a 2017 Center for Disease Control (CDC) report, over 30 million Americans have diabetes but nearly triple that amount have prediabetes—84 million and only 10% know they have it. In most cases, prediabetes will morph into diabetes but it doesn’t have to. Prediabetes as its name implies is the stage prior to an

Colorectal Cancer is the second-leading killer in the U.S., and according to the American Cancer Society (ACS), over 140,000 new cases of colorectal cancer will be diagnosed and over 50,000 will die from the disease in 2018. ACS also notes that “Overall, the lifetime risk of developing colorectal cancer is about 1 in 22 (4.49%)

We established a competition for the best original scientific paper accepted for publication in our journal, Gender and the Genome, to encourage the receipt of high quality original studies for publication. The entries were required to have included gender as a variable in their research protocols, thus assessing the relevance of sex and gender to

Last summer we wrote about the perils of e-cigarettes and vaping in our blog (E-Cigarettes: When Smoke Gets in Your Eyes) that are marketed to young people who want to be hipsters, not knowing how dangerous the ingredients in e-cigarettes really are. In fact, there has been an ongoing battle among the U.S. Food and Drug Administration (FDA), manufacturers and distributors to disclose and label

One of this year’s most significant medical advances involves detecting the progress of cancer through biomarkers in the blood. While solid tissue biopsies can pinpoint tumor size and activity within a specific area, noninvasive liquid biopsies can provide greater insight into the genetics of tumor cells taken from a blood sample. Typically, cancerous tumors shed

Young adults and children suffering with leukemia and lymphoma now have hope as a new CAR-T Therapy Tisagenlecleucel, developed and manufactured by Novartis, has been recommended by an oncology advisory panel of The US Food and Drug Administration (FDA). Many experts believe CAR-T Therapy presents a paradigm shift in how we approach and treat cancer.